When

Saturday, November 08, 2025

8:30 PM-10:00 PM ET

WheRE

Live Stream

faculty
Matthew P. Giannetti, MD
Instructor, Harvard Medical School
Allergy and Immunology
Associate Director
Brigham and Women’s Hospital Mastocytosis Center
Boston, Massachusetts
Anne L. Maitland, MD, PhD
Associate Professor, Department of Medicine - Rheumatology
Medical Director, The Ehlers Danlos Institute
Medical University of South Carolina
Charleston, South Carolina
Tsewang Tashi, MD
Associate Professor
Hematology & Hematologic Malignancies
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah

Target Audience

The design of this activity addresses the needs of clinical immunologists, allergists, dermatologists, gastroenterologists and hematology/oncology clinicians and other healthcare professionals who manage patients with nonadvanced systemic mastocytosis (SM).

Program Overview

Nonadvanced SM is a rare, often misdiagnosed condition associated with high symptom burden and significant quality-of-life impact. This interactive program features a didactic overview of pathophysiology, diagnosis, and evolving treatment strategies of nonadvanced SM, followed by a fun and engaging Medical Jeopardy™-style game to reinforce key concepts.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Explain the underlying causes and effects of nonadvanced SM, with an emphasis on its clinical manifestations and the pathophysiological basis for targeted therapies

  • Differentiate SM, including indolent forms, by recognizing key symptoms and appropriately utilizing laboratory and genetic testing

  • Summarize clinical trial findings for emerging and established therapies, including FDA-approved treatments

  • Tailor treatment plans for nonadvanced SM by incorporating clinical evidence, safety considerations, patient-reported outcomes, shared decision-making, and patient education

Disclosure of Unlabeled Use

This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integritas does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Prefer to participate in-person? Register for our live event at ExchangeCME.com/SMOrlandoLive.

 

Register Now

attend event
Related events
DEC
05
2025
Case-in-Point Live Meeting
1.50 CME

From Indolent to Aggressive

Case-Based Strategies Across the Spectrum of Systemic Mastocytosis

Time: 11:00 AM-1:00 PM ET
Venue: Orange County Convention Center
Location: Orlando, FL
Faculty: Matthew P. Giannetti, MD ; Brian Chernak, MD; Tsewang Tashi, MD
DEC
05
2025
Case-in-Point Live Stream
1.50 CME

From Indolent to Aggressive

Case-Based Strategies Across the Spectrum of Systemic Mastocytosis

Time: 11:30 AM-1:00 PM ET
Venue: Live Stream
Location: Live Stream
Faculty: Matthew P. Giannetti, MD ; Brian Chernak, MD; Tsewang Tashi, MD